CXCL1 and breast cancer: Moreover, western blotting analysis revealed an increase in ABCG2 and LC3-II accumulation, as well as a decrease in SQSTM1/p62 expression in breast cancer cells treated with CXCL1 for 24 h (Fig. 2B).